-
Protect ports and ensure peace of mind.
Disinfect and protect with alcohol-containing caps.
-
Introducing our newest port protectorLEARN MORE
3M? Curos? Stopper Disinfecting Cap for Open Female Luers
3M™ Curos™ Disinfecting Port Protectors
Curos disinfecting port protectors are alcohol-containing caps that twist onto I.V. access points for disinfection and protection. Consistent use of Curos disinfecting caps on I.V. needleless connectors is associated with decreased central line associated bloodstream infections (CLABSIs).
-
Disinfects in 1 minute. Protects ports for up to 7 days.
Each Curos disinfecting port protector contains 70% isopropyl alcohol (IPA). The IPA bathes the surfaces of the port and disinfects it in 1 minute.
All patients, all access points, all the time.
-
3M's Curos disinfecting port protectors is the only brand on the market that has offerings to help reduce risks across all intraluminal access points.
Needleless Connectors
3M? Curos? Disinfecting Cap for Needleless Connectors
Needleless Connectors
3M? Curos? Disinfecting Cap for Needleless Connectors
Needleless Connectors
3M? Curos Jet? Disinfecting Cap for Needleless Connectors
Needleless Connectors
3M? Curos Jet? Disinfecting Cap for Needleless Connectors
Male Luers
3M? Curos Tips? Disinfecting Cap for Male Luers
Male Luers
3M? Curos Tips? Disinfecting Cap for Male Luers
Tego® Hemodialysis Connectors
3M? Curos? Disinfecting Cap for Tego? Hemodialysis Connectors
Tego® Hemodialysis Connectors
3M? Curos? Disinfecting Cap for Tego? Hemodialysis Connectors
Stopcock
3M? Curos? Stopper Disinfecting Cap for Open Female Luers
Stopcock
3M? Curos? Stopper Disinfecting Cap for Open Female Luers
Catheter Hub
3M? Curos? Stopper Disinfecting Cap for Open Female Luers
Catheter Hub
3M? Curos? Stopper Disinfecting Cap for Open Female Luers
3M™ Curos™ Disinfecting Port Protectors achieved a 99.99% reduction in 6 microbes commonly associated with CLABSI*
-
The effectiveness of Curos disinfecting port protectors was tested in vitro against**: Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Candida albicans, Pseudomonas aeruginosa, and Candida glabrata. All test samples exceeded the minimum 4-log reduction after one minute. (3M data on file.)
Advantages Over Scrubbing
The traditional standard of care in port disinfection has been a thorough manual scrub of the port with an alcohol pad, often referred to as “scrubbing the hub.“ Curos disinfecting port protectors provide several advantages over the scrub the hub protocol:
-
Save time
Curos alcohol-impregnated caps provide fast passive disinfection, saving nurses valuable time compared to most scrub the hub protocols. In addition, no drying time is required to achieve disinfection.
-
Provide a physical barrier
They provide a physical barrier to contamination between accesses, for up to 7 days.
-
Remove user technique variation
Once a Curos cap is twisted into place, it provides consistent disinfection.
-
Provide visual confirmation
Curos caps’ bright color help caregivers verify that a port is clean at a glance.
Download 3M’s quick guides to 2016 Infusion Therapy Standards of Practice.
Infusion Therapy Standards of Practice - 2016
Standard 34.2 - Disinfect needleless connectors prior to each entry into the device.
Practice Criterion C - Recognize that needleless connectors are potential sites for intraluminal microbial contamination and require careful adherence to infection prevention practices. (Level IV)
Needleless Connectors “Should be consistently and thoroughly disinfected using alcohol, tincture of iodine, or chlorhexidine gluconate/alcohol combination prior to each access.”
Practice Criterion G – The use of passive disinfection caps containing disinfecting agents (e.g., isopropyl alcohol) has been shown to reduce intraluminal microbial contamination and reduce the rates of central line-associated bloodstream infection (CLABSI). Use of disinfection caps on peripheral catheters has limited evidence but should be considered.
Practice Criterion I – Ensure that disinfecting supplies are readily available at the bedside to facilitate staff compliance with needleless connector disinfection. (Level V)
Society for Healthcare Epidemiology of America (SHEA) 2014 Update
“Use an antiseptic-containing hub/connector cap/port protector to cover connectors.”
(quality of evidence: 1-highest level)
Read the Clinical Evidence
Video Resources
-
Request a Product Evaluation
-
How to Use Videos
-
3M™ Peak™ Clinical Outcomes Program
The 3M? Peak? Clinical Outcomes Program provides you with the resources and partnership you need to define and achieve the outcomes most important to you, your patients and your organization.
-
Stop Bloodstream Infections Before They Start
As your partner in protecting patients, we want to do everything in our power to help you achieve your goal of zero bloodstream infections. Learn more about free educational resources and evidence-based products to help you stop bloodstream infections before they start.
Explore how science and innovation are transforming the healthcare industry.
Thank You
Thank you for connecting with 3M! We’ll be in touch with you shortly.
Our Apologies...
An error has occurred while submitting. Please try again later...
*For more information regarding organisms associated with central line–associated bloodstream infections, refer to:
Sievert, D. M., Ricks, P., Edwards, J. R., Schneider, A., Patel, J., Srinivasan, A., . . . Fridkin, S. (2013). Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infection Control & Hospital Epidemiology, 34(01), 1-14. doi:10.1086/668770
**Data reflects in vitro findings on Curos? Disinfecting Port Protectors
1. Merrill, et. Al, Impact of Universal Disinfectant Cap Implementation on Central Line-Associated Bloodstream Infections. American Journal of Infection Control. December 2014: Volume 40 (12)
2. Cameron-Watson. Port Protectors in Clinical Practice: An Audit. British Journal of Nursing: (IV Therapy Supplement). 2016: Vol 25 (8)
3. Forcing the Function: Implementation and Evaluation of an IV Port Protector to Decrease CLABSI. Legacy Health, Portland, Oregon: Mary Davis, BSN, RN, CCRN